Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2026-03-27 @ 1:09 PM
Study NCT ID:
NCT00836706
Status:
COMPLETED
Last Update Posted:
2024-08-20
First Post:
2009-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R02-664
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None